SILVER SPRING, Md., July 24, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today took significant action to protect women from breast implant-associated anaplastic large cell lymphoma ...
Accepting a district court ruling reached after remand, a federal appeals panel has opened a long-running breast-implant products liability settlement to women who have waited for years to secure ...
Allergan is taking this action as a precaution following notification of recently updated global safety information concerning the uncommon incidence of breast implant-associated anaplastic large cell ...
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast ...